TP53 and intestinal cancer: Furthermore, this study showed that distinctive expressions of miR-506, targeting genes such as SPHK1, DNMT1, SPL, p53, AE2, or InsP3R3, may be responsible for an increased risk of bowel cancer or severe inflammation.